Abstract |
The results of the clinical study of beforal (butorfanol) ("Spofa", Czechoslovakia), a synthetic analgetic from a class of opiate agonists-antagonists, in 17 cancer patients at all stages of surgical treatment have been summarized. It has been established that beforal is a potent analgetic analogous in antistressor properties to moradol (" Galenika", Yugoslavia), however differing by a more prompt onset and discontinuation of action, thus improving the control over general anesthesia. A comparative assessment of circulation parameters and stress factors ( glucose, cortisol, blood plasma STH) has shown that beforal exceeds fentanyl in the efficacy of prevention of surgical trauma during and after extended cancer surgery.
|
Authors | N A Osipova, V V Petrova, M S Vetsheva, T V Dolgopolova, O V Novikova, E I Mozgovaia, N A Loseva |
Journal | Anesteziologiia i reanimatologiia
(Anesteziol Reanimatol)
1993 Sep-Oct
Issue 5
Pg. 8-12
ISSN: 0201-7563 [Print] Russia (Federation) |
Vernacular Title | Butorfanol tartrat (beforal) v onkokhirurgii. |
PMID | 8116910
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
|
Topics |
- Adult
- Aged
- Analgesia
- Butorphanol
(therapeutic use)
- Female
- Humans
- Male
- Middle Aged
- Neoplasms
(surgery)
- Pain, Postoperative
(prevention & control)
|